Publicacions
-
Bray, L, Blake, L, Protheroe, J, Nafria-Escalera B, De Avila, MAG, Angstrom-Brannstrom, C, Forsner, M, Campbell, S, Ford, K, Rullander, AC, Robichaud, F, Nolbris, MJ, Saron, H, Kirton, JA and Carter, B.
Children's pictures of COVID-19 and measures to mitigate its spread: An international qualitative study
HEALTH EDUCATION JOURNAL . 80(7): 811-832. Nº de cites: 15
-
Brotons-de los Reyes P, Pérez-Argüello A, Launes-Montana C, FRANCESC TORRENTS GÓMEZ, Subirats MP, Saucedo-Verdes J, Claverol J, García-García JJ, Rodas G, Fumadó V, Jordán-García I, Gratacós E, Bassat Q and Munoz-Almagro C.
Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES . 110: 363-370. Nº de cites: 13
-
Brotons-de los Reyes P, Jordán-García I, Bassat Q, Henares-Bonilla D, Fernández de Sevilla-Estrach M, Ajanovic S, Redin-Alonso A, Fumadó V, Baro B, Claverol J, Varo R, Cuadras-Palleja D, Hecht J, Barrabeig I, García-García JJ, Launes-Montana C and Munoz-Almagro C.
The Positive Rhinovirus/Enterovirus Detection and SARS-CoV-2 Persistence beyond the Acute Infection Phase: An Intra-Household Surveillance Study
Viruses-Basel . 13(8): 1598. Nº de cites: 14
-
Alessandrini E, Brako F, Scarpa M, Lupo M, Bonifazi D, Pignataro V, Cavallo M, Cullufe O, Enache C, Nafria-Escalera B, Claverol J, De Taeye L, Vermeulen E, Preston J and Tuleu C.
Children's Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure).
Pharmaceutics . 13(5): 730. Nº de cites: 16
-
Faulkner SD, Sayuri Ii S, Pakarinen C, Somers F, Vicente Edo MJ, Prieto Remon L, Diaz Ponce A, Gove D, Ferrer E, Nafria-Escalera B, Bertelsen N, Boudes M, Brooke N, Moutet A and Fahy N.
Understanding multi-stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed-methods study
HEALTH EXPECTATIONS . 24(2): 601-616. Nº de cites: 10
-
Radu R, Hernández-Ortega S, Borrega O, Palmeri A, Athanasiou D, Brooke N, Chapí I, Le Corvec A, Guglieri M, Perera A, Garrido-Aguirre J, Ryll B and Nafria-Escalera B.
Global Collaborative Social Network (Share4Rare) to Promote Citizen Science in Rare Disease Research: Platform Development Study.
jmir formative research . 5(3): .
-
Turner M, Hildebrand H, Fernandes RM, de Wildt SN, Mahler F, Hankard R, Leary R, Bonifazi F, Nobels P, Cheng K, Attar S, Rossi P, Rocchi R, Claverol J, Nafria-Escalera B and Giaquinto C.
The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children.
Pharmaceutical Medicine . 35(2): 71-79. Nº de cites: 14
-
Bray L, Carter B, Blake L, Saron H, Kirton JA, Robichaud F, Avila M, Ford K, Nafria-Escalera B, Forsner M, Nilsson S, Chelkowski A, Middleton A, Rullander AC, Mattsson J and Protheroe J.
"People play it down and tell me it can't kill people, but I know people are dying each day". Children's health literacy relating to a global pandemic (COVID-19); an international cross sectional study.
PLoS One . 16(2): . Nº de cites: 29
-
Tsang VWL, West L, Woods C, Koh CJ, McCune S, Mullin T, Smith SR, Gaillard S, Claverol J, Nafria-Escalera B, Preston J, Dicks P and Thompson C.
Role of Patients and Parents in Pediatric Drug Development
THERAPEUTIC INNOVATION & REGULATORY SCIENCE . 53(5): 601-608. Nº de cites: 11
-
Nordenmalm S, Kimland E, Ligas F, Lehmann B, Claverol J, Nafria-Escalera B, Tötterman AM and Pelle B.
Children's views on taking medicines and participating in clinical trials
ARCHIVES OF DISEASE IN CHILDHOOD . 104(9): 900-905. Nº de cites: 6